TransHeps AG

AI Quick Summary

Serving global Pharma Drug Developer and Regulators by providing the MetaHeps assay as a decision-enabling DILI drug development tool for DILI causality assessment in clinical studies. TransHeps is a spin-off the University of Zurich and offers services and expertise related to the understanding of drug-induced liver injury (DILI), using our core MetaHeps technology. We additionally offer our expertise to advice how to integrate our MetaHeps technology into the clinical study design, along with standard and novel biomarkers of liver injury, and services in the form of in vitro assays focused on assessing risks of intrinsic DILI and the underlaying mechanisms of liver toxicity. We are dedicated to the investigation and understanding of the mechanisms behind DILI, towards stream-lining drug development processes and patient care. TransHeps is the only industrial service provider of the MetaHeps assay.

Organization Metadata

• Organization Name: TransHeps AG
• Date: 11/25/2024 1:32:55 PM
• Administrators:
  • Martin Birk

Organization Description

Serving global Pharma Drug Developer and Regulators by providing the MetaHeps assay as a decision-enabling DILI drug development tool for DILI causality assessment in clinical studies. TransHeps is a spin-off the University of Zurich and offers services and expertise related to the understanding of drug-induced liver injury (DILI), using our core MetaHeps technology. We additionally offer our expertise to advice how to integrate our MetaHeps technology into the clinical study design, along with standard and novel biomarkers of liver injury, and services in the form of in vitro assays focused on assessing risks of intrinsic DILI and the underlaying mechanisms of liver toxicity. We are dedicated to the investigation and understanding of the mechanisms behind DILI, towards stream-lining drug development processes and patient care. TransHeps is the only industrial service provider of the MetaHeps assay.